Introduction
Cellular senescence, the state of a stable long-term loss of replicative capacity, restricts cells from propagation (Kuilman et al., 2010) . Senescence is ultimately driven by DNA disruption. One form of senescence, replicative senescence, occurs in cultured human cells that reach an intolerable telomeric shortening or uncapping (Dimri, 2005) . The second, accelerated or premature senescence, is independent of telomeres and occurs in mouse embryonic fibroblasts (MEFs) that endure culture-stress, and also arises in human and mouse cells following genotoxic stress or oncogene activation (Campisi and d'Adda di Fagagna, 2007) . Senescence involves a program of signal transduction that culminates in terminal, irreversible growth cessation, accompanied by a distinct set of alterations in the cellular phenotype, such as an enlarged and flattened cell shape (Campisi and d'Adda di Fagagna, 2007) . Regardless of the signals that induce premature senescence, the two major tumor suppressor pathways p53-p21 WAF1 and pRb-p16 INK4a lie at the heart of the machinery controlling the execution and maintenance of this response (Campisi and d'Adda di Fagagna, 2007; Collado and Serrano, 2010; and Kuilman et al., 2010) .
In murine cells the ARF-p53 pathway has a dominant role, whereas in human cells pRb-p16
INK4a seems to be equally important (Campisi and d'Adda di Fagagna, 2007) . Recent studies support the role for cellular senescence as a natural barrier to tumor development (Collado and Serrano, 2010) . This concept has been demonstrated by exploiting p53-driven senescence to limit cancer progression in an existing malignancy using a mouse sarcoma model (Ventura et al., 2007) .
P53 has been demonstrated to be essential for cellular senescence in cultured cells and in vivo mouse models. Signals that induce DNA damage response, such as ionizing irradiation (IR) and chemotherapeutic drugs, or telomere dysfunction, drive senescence through the p53-p21 pathway (Zuckerman et al., 2009 ). Impairment of DNA repair genes, such as BRCAI or DNA ligase IV, allows DNA to accumulate damage, which induces premature senescence in MEFs; this can be evaded by p53 inactivation (Frank et al., 2000) . Irreparable DNA lesions sustain the ATM/ATR-p53 response, maintaining the senescence phenotype (Campisi and d'Adda di Fagagna, 2007; Di Micco et al., 2008) . Likewise, oncogenic activation triggers senescence, which may involve a DNA damage response, as in the case of Ras or Mos, or be independent of DNA damage as with Runx1 . In both cases the response involves p53. Oncogenic activation of p53 is mediated by ARF, encoded by the INK4a locus (Gil and Peters, 2006) . The mechanism by which p53 promotes senescence is only partially understood. P53 target genes have been implicated in the induction of senescence, these include the CDK inhibitor p21, the plasminogen activator inhibitor-1 (PAI-1) (Mu and Higgins, 1995; Serrano et al., 1997) and MIC-1, a cytokine inducing senescence (Sherman et al., 2007) .
An important regulator of p53 in Human Papilloma Virus (HPV) infected cells is E6AP, an E3 ligase that promotes p53 degradation in infected cells (Scheffner et al., 1990) , reviewed in (Howley, 2006) . E6AP is encoded by the UBE3A locus, which is mutated in Angelman's Syndrome, a human neurodevelopmental disorder (Matsuura et al., 1997) reviewed in (Matentzoglu and Scheffner, 2008) . It is the prototype of the subfamily of E3 ligases that covalently bind ubiquitin and are characterized by a C-terminal HECT (homologous to the E6AP C terminus) domain (for review see Scheffner et al., 1993; Talis et al., 1998; Ciechanover, 2006; and Beaudenon and Huibregtse, 2008) . E6AP has also been reported to affect p53 levels in the absence of HPV-E6 (Jiang et al., 1998b and Khan et al., 2006) . In this study we demonstrate a novel role for E6AP in the regulation of cellular senescence. We found that MEFs deficient for E6AP have impaired replicative as well as oncogene-induced senescence. Unexpectedly, in MEFs, E6AP acts as a positive regulator of p53, both at the basal level as well as in response to stress. This explains the impaired senescence response of the E6AP KO MEFs, leading to enhanced growth and transformed phenotype in response to oncogenic activation.
Results
Absence of E6AP enhances the growth of mouse embryo fibroblasts E6AP has been linked to a number of cell cycle regulators, including p53, PML, RING1B and the cyclin-dependent kinase inhibitor p27 (Mishra et al., 2009) . It was therefore of interest to examine the effect of E6AP deficiency on the growth rate of primary early passage MEFs. For this purpose we have compared MEFs from wild-type (WT) mice with E6AP homozygous knock-out (KO) mice. For each experiment at least three different MEF samples, derived from different embryos were compared. The population doubling of WT versus E6AP KO MEFs was compared over 25 passages using an established 3T3 protocol (Todaro and Green, 1963) . As controls we have used the p53 KO MEFs, which have been shown to exhibit a very fast population doubling (Harvey et al., 1993) . As shown in Figure 1a , MEFs lacking E6AP have a faster population doubling than WT MEFs. This growth rate was between that of WT and p53 KO MEFs. This suggests that E6AP regulates the growth rate of MEFs, which increases in the absence of E6AP.
To gain a better understanding of the enhanced growth rate of E6AP KO MEFs, we have compared the rate of cell proliferation between WT and E6AP KO MEFs using three assays. First, the numbers of MEFs were compared over 9 days under standard culture conditions. Equal numbers of WT and E6AP KO MEFs were plated and cell numbers were compared at days 3, 6 and 9. As shown in Figure 1b (left), the number of cells at days 6 and 9 was greater among the E6AP KO than the WT MEFs. The number of dead cells in these samples, as monitored by flow cytometry using dye exclusion, was low and comparable between WT and E6AP-KO cells (Figure 1b, right) . Second, we measured the effect of E6AP on cell growth using a colony growth assay. WT and E6AP KO MEFs were plated at low density, and the effect on cell growth under normal culture conditions was monitored 14 days later. As shown in Figure 1c , the E6AP KO MEFs formed multiple colonies of varying sizes, whereas the WT MEFs survived but did not form colonies, as previously described (Sage et al., 2000; Bardeesy et al., 2002) . These data are summarized in Figure 1d . Third, we determined more directly the effect of E6AP on the rate of cell proliferation using the BrdU incorporation assay, which measures DNA synthesis. E6AP KO MEFs incorporated more BrdU than WT MEFs (Figure 1e ), supporting the increased rate of cell division. Overall, these results demonstrate a role for E6AP in the regulation of cell growth, where MEFs lacking E6AP proliferate at a higher rate than normal cells.
E6AP is essential for replicative senescence
Although the enhanced population doubling of the E6AP KO cells was consistent over 25 passages, it was noted that even at the early passages (4-8) the E6AP KO MEFs avoided the retarded growth typically seen in normal MEFs over these passages (Figure 2a ). The slow growth during these passages is typical of normal MEFs undergoing cellular senescence (culture stress-induced senescence) (Parrinello et al., 2003) . This therefore raises the question of whether E6AP KO MEFs undergo senescence to the same extent as WT MEFs? To answer this question, WT and E6AP KO MEFs at passage six were fixed and the extent of cellular senescence was measured using the senescence-associated beta-galactosidase (SA-b-Gal) staining (Dimri et al., 1995; Collado and Serrano, 2006) . As seen in Figure 2b , the extent of senescence in the WT MEFs was greater than in the E6AP KO MEFs. A summary of three experiments is shown in Figure 2c . Two other lines of evidence support the impaired ability of E6AP-deficient MEFs to undergo senescence. First, we measured the expression of two known markers of senescence: p21 and the PAI-1 (Mu and Higgins, 1995; Serrano et al., 1997; Kortlever et al., 2006) . The protein and mRNA levels of p21 were higher in WT than in E6AP KO MEFs as measured by western blot analysis and by quantitative real-time PCR (qPCR), respectively ( Figure 2d) . Likewise, the levels of PAI-1 mRNA were 2.5 fold lower in the E6AP KO MEFs than in the WT controls (Figure 2e ), consistent with its impaired senescence. Second, we have compared the morphology of WT versus E6AP KO MEFs. Low passage MEFs undergoing senescence are known to exhibit a large and flat morphology (Smith and Lincoln, 1984) . By contrast to the WT MEFs, which acquired the senescence phenotype, the E6AP KO MEFs did not acquire these characteristics (Figure 2f ). Together, these results demonstrate a role for E6AP in the regulation of E6AP is required for replicative and oncogene-induced senescence in MEFs Y Levav-Cohen et al normal replicative senescence in cultured MEFs. The analyses for cellular senescence described in Figure 2 were repeated over multiple passages starting at passage 2 up to passage 25. E6AP KO MEFs never manifested a senescence phenotype over any of the passages examined. This strongly suggests that E6AP-deficient MEFs have impaired ability to undergo senescence, rather than having a delayed senescence response. To ascertain that the observed effect of E6AP deficiency on cell growth and senescence was specific to E6AP loss and not a result of other genomic alteration, E6AP expression was downregulated in WT MEFs (p6) in G1 phase of cell cycle is indicated, as measured by PI using flow cytometry; Po0.001. *P-value calculated using t-test. Figure 1A) . This reconstitution restored the protein levels of p21 (Supplementary Figure 1A) , and consistent with it also the normal regulation of colony growth (Supplementary Figure 1B) , and the capacity to undergo senescence, as determined by expression of SA-b-Gal and the acquisition of a flattened morphology (Supplementary Figure 1C) . Interestingly, the function of E6AP in cellular senescence was partially restored by reconstitution with a catalytic mutant, suggesting that the E3 ligase activity may not be critical for this function of E6AP (Supplementary Figure 1D) . Consistent with this finding, downregulation of E6AP, using lentivirus expressing short hairpin RNA (shRNA) for E6AP, in WT MEFs (Supplementary Figure 1E ) led to increased cell growth, while the wobble shRNA to E6AP had no effect (Supplementary Figure 1F) . Overall, these results provide strong evidence supporting a direct role for E6AP in the growth control of the E6AP KO MEFs.
E6AP is required for replicative and oncogene-induced senescence in MEFs

E6AP is required for normal accumulation of p53
P53 is a major regulator of cellular senescence (reviewed in Papazoglu and Mills, 2007; Rodier et al., 2007; and Zuckerman et al., 2009) . As E6AP has been shown to act as a regulator of p53 in HPV-infected cells (for review see Huibregtse et al., 1991; Scheffner et al., 1990 Scheffner et al., , 1993 Longworth and Laimins, 2004; andBeaudenon and Huibregtse, 2008) and in certain cells, such as prostate MEFs (p6) . Photographs are at the same magnification ( Â 400). Pictures were taken with the Nikon inverted microscope (TS100, Nikon, Melville, NY, USA). *P-value calculated using t-test.
E6AP is required for replicative and oncogene-induced senescence in MEFs Y Levav-Cohen et al (Khan et al., 2006) and neuronal cells (Jiang et al., 1998b and Jana, 2008) , it was important to examine the effect of E6AP deficiency on the expression levels of p53. For this purpose we compared the levels of p53 expression between WT and E6AP KO MEFs, where p53 KO MEFs were used as a control. Surprisingly, we found that the basal expression level of p53 in E6AP KO MEFs is lower than in WT control ( Figure 3a ). This suggested that in MEFs, E6AP is required for maintaining basal levels of p53.
To establish whether E6AP also regulates p53 levels in response to stress, we measured the effect of E6AP on the accumulation of p53 in response to genotoxic stress. WT and E6AP KO MEFs were exposed to IR; 3Gy and p53 protein levels were monitored at different times (1-24 h). In the WT MEFs, p53 protein accumulated following IR, with maximal levels reached at 2 h, followed by an oscillatory response, as previously reported (Lev Bar-Or et al., 2000 and Lahav et al., 2004) . Consistent with the lower basal levels of p53 in the E6AP KO MEFs, the accumulation of p53 in response to IR was also impaired relative to the WT controls (Figure 3b) . A similar result, albeit with different accumulation kinetics, was observed following exposure to UV light (20 j/m 2 ) as the source of DNA damage (Figure 3c ). Both the extent of p53 accumulation and the duration of the response were compromised in the E6AP KO MEFs.
The specificity of E6AP on the effect on p53 accumulation in response to stress was verified by downregulation of E6AP in WT cells and by reconstituting E6AP expression in the KO MEFs. WT MEFs expressing shRNA for E6AP had lower p53 protein levels, both at the basal level (lanes 1-2, Supplementary Figure 2A ) and following exposure to UV light (20 j/m 2 ), as compared with untreated WT MEFs (lanes 3-10, Supplementary Figure 2A) . As controls, WT MEFs were infected with the same inducible shRNA virus, which in contrast bore an shRNA sequence to E6AP with two nucleotides substituted (wobble shRNA), which therefore did not downregulate E6AP expression. Consistent with this result, reconstitution of E6AP KO MEFs with E6AP expression using lentivirus-mediated E6AP expression restored the basal levels of p53 to levels similar, or even higher, than those in the WT MEFs (lanes 1-3, Supplementary Figure 2B) . In response to UV light, the accumulation of p53 in the E6AP-reconstituted cells was restored to levels equivalent to those observed in the WT MEFs (Supplementary Figure 2B) . Similar results were obtained with a reconstitution with a catalytic mutant of E6AP (Supplementary Figure 2C ). Taken together, these results strongly support a positive role for E6AP in the regulation of p53 under normal and genotoxic stress conditions.
In an attempt to define the mechanism of p53 regulation by E6AP we measured the effect of E6AP on the half-life of p53 using a cycloheximide chase experiment. We found that E6AP loss does not shorten the half-life of the p53 protein (Supplementary Figure  5B) . Further, we have examined whether E6AP affects the extent of p53 ubiquitination. Cells from both genotypes were treated with MG132 to block proteasomal degradation and the extent p53 ubiquitination. This analysis revealed no effect of E6AP on the ubiquitination of p53 (Supplementary Figure 5C) . Consistent with these results we found no difference in the extent of p53 phosphorylation on N-terminal sites (Ser15 and Ser20) (Supplementary Figure 5D) . Together, these results suggest that E6AP does not affect the protein stability of p53 in MEFs. Therefore, we next examined whether E6AP affects p53 at the transcriptional level, and found that E6AP does not affect p53 transcription (Supplementary Figure 5A ). We therefore propose that the most likely level at which E6AP positively regulates p53 is by enhancing the rate of its translation. This suggestion is supported by the finding that the E3 ligase activity of E6AP is not essential for this regulation of p53 (Supplementary Figure 2C) .
E6AP is required for the cellular response to stress
The observed positive role of E6AP in the regulation of p53 suggested that E6AP may affect the response of MEFs to stress signals, which are known to be regulated by p53. For this purpose we compared the growth of WT and E6AP KO MEFs under stress conditions using a colony assay (Ferbeyre et al., 2002) . The two types of MEFs were sparsely seeded in 10 cm dishes until colonies were visible. Colonies were then exposed to low levels of serum (0.1%) cultured for E6AP is required for replicative and oncogene-induced senescence in MEFs Y Levav-Cohen et al additional 2-5 days. As shown in Figure 4a , no visible colonies were observed in the WT MEFs, whereas many colonies grew in the E6AP KO dishes. Next we exposed the MEFs to IR as a source of genotoxic stress. WT and E6AP KO MEFs were seeded on 10 cm dishes, and 24 h later cells were exposed to IR (4 or 8 Gy) and continued growth for additional 14 days before harvested for staining and counting. As seen in Figure 4b , no WT MEFs colonies grew following exposure to IR. By marked contrast, multiple colonies grew in the E6AP KO dish after exposure to 4 Gy, and even a few colonies grew following 8 Gy of IR. This ability of the E6AP KO MEFs to partially overcome IR-induced growth inhibition is similar, albeit to a much lesser extent, to that of p53 KO MEFs (Figure 4b ). These results strongly implicate E6AP in the cellular response to stress conditions.
E6AP deficiency enhances the transformation potential of MEFs
As demonstrated above, the E6AP KO MEFs exhibited multiple characteristics suggestive of a transformed phenotype, being consistent with an impaired accumulation of p53. To assess more directly the contribution of E6AP deficiency to the transformed state of MEFs, we employed two assays. In the first, we compared the anchorage independent growth ability of the MEFs using a soft agar assay. Late passage (p40) of E6AP KO and WT MEFs were plated in soft agar and grown for 14 days, before harvest, staining and scoring. As shown in Figure 5a , the number of the colonies, of three independent experiments, was much greater in the E6AP KO MEFs than the WT MEF.
The second approach was to introduce the Ras oncogene and measure the effect of E6AP on the cellular response of MEFs to oncogenic stress. For this (b) Percentages of SA-b-gal-positive MEFs derived from WT and KO E6AP that were infected at passage five with a retrovirus expressing H-rasV12 or with empty vector control (pBabe-Puro) and selected by puromycin (2 mg/ml) for 4 days. Values are mean ± s.d. for triplicates. *Po0.01 versus respective non-Ras control by Student's t-test. (c) Representative growth curves corresponding to the indicated cell culture (also described in a), transduced with empty vector (control) or with H-rasV12-expressing retroviruses. Each curve was performed at least six times, and each time point was determined in triplicate (Po0.0001).
E6AP is required for replicative and oncogene-induced senescence in MEFs
Y Levav-Cohen et al purpose the two types of MEFs were infected with retrovirus expressing activated Ras Val 12 and the response to Ras was monitored. Oncogenic activation induces premature senescence in mouse primary cells (Serrano et al., 1997) and this has been recently shown to involve a DNA damage response (Bartkova et al., 2006) . We therefore compared Ras-induced senescence between the two MEF types. As clearly shown in Figure 5b and in Supplementary Figure 3 , Ras activation induced an efficient senescence in the WT MEFs (over 60%, Figure 5b ). On the other hand, Ras activation did not induce significant levels of senescence in E6AP KO MEFs. In fact, the extent of Ras-induced senescence in the E6AP KO MEFs was lower than the spontaneous senescence in the WT MEFs (Figure 5b ). It is important to note that the extent of spontaneous replicative senescence was already high in the WT control MEFs. The effect of Ras expression on the growth of the two MEF types was monitored by cell growth over 8 days post infection. As seen in Figure 5c , WT MEFs had a short burst of growth followed by growth inhibition. By marked contrast, the E6AP KO MEFs continued to grow in the presence of Ras, with a growth rate faster than in the absence of Ras (Figure 5c ). The reduced growth rate in the E6AP KO MEFs at day 8 resulted from high density and depleted nutrient in the cultured dishes. Next we measured cellular growth of Ras expressing cells under stress conditions using a colony growth assay. The two MEF types were plated sparsely and grew in the presence of either 10 or 0.1% serum. WT MEFs expressing activated Ras grew a few colonies at 10% but barely any colonies grew at 0.1% serum. By marked contrast E6AP KO MEFs expressing activated Ras generated E6AP is required for replicative and oncogene-induced senescence in MEFs Y Levav-Cohen et al multiple large colonies at 10%, and even several colonies grew at 0.1% serum (Figures 6a and b) . As controls we used the p53 null MEFs, which are known to overcome Ras-induced growth inhibition under stress conditions. Further, the same set of MEFs was subjected to genotoxic stress. Two doses of IR (4 and 8 Gy) were applied to each type of MEFs and the cells were then cultured for additional 14 days. As shown in Figure 6c , WT MEFs did not generate any colonies following 4 Gy IR, whereas E6AP KO generated multiple colonies. Similar results, although less pronounced, were observed following exposure to 8 Gy. These results are summarized in Figure 6d . p53 expression levels are elevated in response to oncogenic stress (Serrano et al., 1997) . Consistent with the results described above the accumulation of p53 expression in response to Ras activation was compromised in the E6AP KO MEFs (Figure 6e ).
Finally, we tested whether the effect of E6AP on cell transformation can also be demonstrated in vivo in a xenograft transplantation assay. WT and E6AP KO MEFs were infected with activated Ras, and injected subcutaneously into the flanks of nude mice. First signs of tumors were seen at day 18 after transplantation, these were generated predominantly from the E6AP KO MEFs, with only 2 small tumors derived from the WT MEFs (Figure 6f ). This difference was maintained and was much more evident at day 36 and day 56 of the experiment (Figure 6f ). In addition to the size of the tumors, the number of tumors per injection site was greater (up to 5) in the E6AP KO MEFs derived xenografts (Figure 6g and Supplementary Figure 4) . These results provide a strong support for the oncogenic properties of the E6AP KO MEFs in collaboration with Ras in transplanted animals. Overall, the results described in this section demonstrate a role for E6AP in the cellular response to oncogenic and genotoxic stress.
Discussion
A growing body of evidence suggests that cellular senescence is an important and evolutionarily conserved tumor suppression mechanism, which acts as a natural barrier to cell immortalization and transformation (Campisi, 2005; Di Micco et al., 2007) . MEFs have been widely used to dissect the regulation and the phenotype of cellular senescence. The p53-p21 WAF1 and pRb-p16
INK4a tumor suppressor pathways form the major network controlling cellular senescence. In mouse cells, disruption of p53 alone is sufficient to overcome the senescence response, whereas inactivation of pRb is insufficient (Dannenberg et al., 2000 and Sage et al., 2003) . In this study we demonstrate a role for E6AP in the regulation of cellular senescence. MEFs deficient for E6AP exhibit an enhanced growth, associated with an increased rate of proliferation relative to WT MEFs (Figure 1 ). Strikingly, low as well as advanced passage MEFs deficient for E6AP escape cellular senescence (Figure 2) , resulting in an enhanced doubling population consistent over 25 passages (Figure 1a ). This suggests that the impaired senescence of E6AP KO MEFs does not result from premature or delayed onset of senescence.
Oncogene-induced senescence is a key stress signal that triggers the tumor suppression response. It has been demonstrated that oncogenic signaling is associated with a DNA damage response, involving the ATM/ATR-p53 signaling pathway (Halazonetis et al., 2008 and Rodier et al., 2009) . For example, the activation of RAS or MOS involves a DNA damage response via p53 (Di Micco et al., 2007) . However, oncogenes, like RUNX1 induce p53-dependent senescence without DNA damage response . We have chosen activated Ras to examine the effect of E6AP on oncogene-induced senescence. Intriguingly, we found that E6AP is required for the cellular response to activated Ras. E6AP KO MEFs are refractory to Rasmediated cellular senescence (Figure 5b and Supplementary Figure 3) , and in fact continue to proliferate in the presence of Ras ( Figure 5c ). As replicative and oncogene-induced senescence in MEFs require p53, we examined the link between E6AP and p53 in MEFs. Surprisingly, we found that E6AP is required for the maintenance of basal expression levels of p53 (Figure 3a) , and for the efficient accumulation of p53 in response to DNA damage (Figures 3b and c ; IR and UV light, respectively). In E6AP KO MEFs, the extent and duration of p53 accumulation is compromised (Figures 3b and c) . Consistent with this is the impaired accumulation of the p53 target genes, p21 and PAI-1, which have a role in cellular senescence (Figures 2d and  e) . Likewise, accumulation of p53 in response to Ras activation is impaired in E6AP KO MEFs (Figure 6e ). This impairment in p53 accumulation explains, at least in part, the impaired replicative senescence and oncogene-induced senescence response of the E6AP KO MEFs. The deregulation of p53 can be restored by reconstitution of the KO MEFs with E6AP. Conversely, downregulation of E6AP in the WT MEFs recapitulates the deregulation of p53, provides a strong support for the role of E6AP in the regulation of p53 rather than a selection process during embryonic development.
Our results identify a novel role for E6AP in the maintenance of p53 in MEFs, which contrasts published findings that report the contribution of E6AP to p53 degradation in alternative contexts.
A role for E6AP in the degradation of p53 has been observed in HPV-infected cells (Scheffner et al., 1990) , as well as in prostate and neuronal cells (Jiang et al., 1998b; Khan et al., 2006; Mishra and Jana, 2008) . The reason for this opposing effect on p53 regulation is currently unclear. It may involve multiple factors, such as the type of cells (embryonic fibroblasts versus cell lines or HPV-infected cells), or primary cells versus established cultured cells. Further, we found that E6AP does not affect p53 levels in thymocytes undergoing radiation-induced cell death (Supplementary Figure 8) , which is consistent with E6AP KO mice not developing spontaneous T-cell lymphoma. Accordingly, the role of E6AP is required for replicative and oncogene-induced senescence in MEFs Y Levav-Cohen et al E6AP in the regulation of cell growth and cellular senescence would be anticipated to differ in different cell types and/or growth conditions. The mechanism by which E6AP positively regulates p53 in MEFs is yet to be demonstrated. We found that E6AP loss does not affect p53 at the protein stability level (Supplementary Figure 5B ), nor at the transcriptional level (Supplementary Figure 5A ), and therefore propose an effect at the protein translation level as a likely mechanism. This suggestion is supported by the finding that the E3 ligase activity of E6AP is not essential for this regulation of p53 (Supplementary Figure 2C) . Further studies are required to test this possibility. The reduction in p53 protein levels in E6AP-deficient MEFs correlated with reduced activity of p53. This includes an impaired apoptotic response to stress conditions (Supplementary Figure 6A) , and reduced transcriptional activation of apoptotic target genes, such as bax and puma (Supplementary Figure 7A ), as well as p21 and PAI-1 (Figure 2 , Supplementary Figure 7B ), which are required for mediating cellular senescence.
As may be expected from MEFs expressing downregulated levels of p53, the E6AP KO MEFs exhibit a range of transformed phenotypes. These include an enhanced rate of proliferation (Figure 1) , enhanced ability to grow colonies under normal and stress conditions (low serum and DNA damage) (Figures 1c  and 4) , anchorage independent growth (Figure 5a ) and the ability to overcome oncogenic stress ( Figure 6 ). The extent of the E6AP KO MEFs phenotype was largely midway between WT and p53 null MEFs, being consistent with a downregulated p53 response, rather than a complete loss.
Materials and methods
Culturing and 3T3 serial passaging E6AP KO mice (Jiang et al., 1998a) were backcrossed onto C57/B6 background for 10 generations. MEFs were derived from E13.5 embryos of E6AP KO mice or C57/B6 control mice according to standard protocol (Todaro and Green, 1963) . MEFs were cultured in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated FCS, 10 mM non-essential amino acids, 2 mM L-glutamine, 1 mM sodium pyruvate, 10 mM HEPES and 50 mM b-mercaptoethanol. For replicative senescence assays, a 3T3 protocol (Todaro and Green, 1963; Sherr and DePinho, 2000) was followed by counting cells in triplicate and reseeding 1 Â 10 6 cells per 10 cm plate every 3.5 days. The population doubling level (PDL) was calculated using the formula DPDL ¼ log (n f /n 0 )/log 2 , where n 0 is the initial number of cells and n f is the final number of cells (Blasco et al., 1997) .
Immunoblotting and antibodies
Western blot analysis was carried out essentially as previously described (Haupt et al., 1996) . The antibodies used in this study were as follows: anti-mouse p53 polyclonal CM5 (Novocastra), anti-p21 (C-19, Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-actin monoclonal antibody (Ac-40; Sigma Chemical Co., Rehevot, Israel) and anti-E6AP monoclonal antibody (E6AP-330; Sigma Chemical Co).
Growth and colony formation assays
For growth assay, MEFs were seeded at density of 25 000 cells per six wells or 5 or 10 cm plate and harvested after 2/3, 4/6 or 8/9 days, respectively. (For further analysis see Haupt et al., 2009.) For colony formation assay MEFs were seeded at a density of 10 3 cells per 10 cm plate and cultured for 2 weeks, then washed with phosphate-buffered saline, fixed in 70% ethanol for 15 min and stained with Giemsa (Baker, Phillipsburg, NJ, USA) for 15 min, with the exception that for low serum colony assay MEFs were seeded at a density of 5000 cells per 5 cm plate and after 2 weeks culturing, MEFs were subjected to 10 or 0.1% serum for 5 days. For genotoxic stress, MEFs were exposed to 4 or 8 Gy and then cultured for 2 weeks.
Soft agar formation assays
MEFs were resuspended at a density of 10 4 cells in 0.7% agarose in 2 Â RPMI with additives (20% serum, 0.6 g/l L-glutamine, 4 g/l NaHCO3, Pen
Step 20 units/ml) and seeded into 3.5 cm plates coated with 1% agar in 2 Â RPMI with additives. The plates were incubated at 37 1C for 2 weeks. Foci were stained with 0.005% crystal violet and then scored and photographed.
Cell cycle analyses
BrdU incorporation was assayed with anti BrdU antibody (BD Pharmingen, San Diego, CA, USA) according to the manufacturer's instructions. Briefly, 5 Â 10 5 cells were pulsed with 20 mM BrdU for 4 h, harvested and stained with FITCconjugated anti-BrdU antibody and propidium iodide (5 mg/ ml), and cell cycle profiles were analyzed by flow cytometry.
Senescence-associated b-galactosidase staining MEFs were seeded at a density of 5 Â 10 4 cells per well in sixwell plates and 2 days later, cells were washed twice with phosphate-buffered saline and fixed with 2% formaldehyde and 0.2% glutaraldehyde for 5-7 min at room temperature. After phosphate-buffered saline washes, cells were incubated in the staining solution (150 mM NaCl, 2 mM MgCl 2 , 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 1 mg/ml 5-bromo-4-chloro-3-indolyl--D-thiogalactopyranoside (X-Gal) in citric acid-sodium phosphate solution, pH 6.0) at 37 1C without CO 2 for o12 h. The percentage of cells expressing SA b-gal was quantified by inspecting 200 cells per well three times.
Retroviral and lentiviral vectors and gene transfer
Oncogenic Ras was transduced using a pBabe-Puro-based vector expressing a human H-rasV12 cDNA. Retroviralmediated gene transfer was performed as previously described (Serrano et al., 1997) . Reconstitution of E6AP expression was done by using myc-E6AP lentivirus: myc tag was fused to E6AP isoform 1 and inserted, instead of GFP, into pSIN GFP lentiviral vector (Zufferey et al., 1998) . For downregulation of E6AP the following shRNA sequences were used: forward primer: 5 0 -CGCGTCCCCgaagcagttgtatgtggaaTTCAAGAGA ttccacatacaactgcttcTTTTTGGAAAT-3 0 and reverse primer: 5 0 -CGATTTCCAAAAAgaagcagttgtatgtggaaTCTCTTGAAttc cacatacaactgcttc GGGGA-3 0 . These sequences were introduced into pLVTHM lentiviral vector (kindly provided by D Trono). PCMVDR8.91 packaging construct and PMD2.VSVG envelope construct. Lentivirus was generated by transfection of HEK293T, which were used as packaging cell line, with the appropriate lentiviral vector (10 mg) together with the packaging construct (6.5 mg) and the envelop construct, (3.5 mg). Viral collection E6AP is required for replicative and oncogene-induced senescence in MEFs Y Levav-Cohen et al was performed 48 h after transfection. Virus-containing medium from seven transfected HEK293T 10 cm plates were concentrated to 1-2 ml using ultracentrifugation (70 000 g, 2 h) and used to infect cells.
Cell infection was preformed by incubating virus containing medium in the presence of polybrene (8 mg/ml) for 6 h. After 2 days later, cells infected with myc-E6AP, were checked for stable expression of E6AP by western blot, whereas cells infected with shRNA for E6AP were first treated with 0.2 mg/ml doxycycline for 72 h and then checked for downregulation of E6AP by western blot.
Real-time PCR assay Cellular RNA was isolated by Tri Reagent (MRC Inc., Cincinnati, OH, USA) using the manufacturer's instructions. DNA was removed from the samples using DNAse treatment (DNA-free kit: Applied Biosystems, Foster city, CA, USA). cDNA was synthesized from the purified RNA using M-MLV reverse transcription kit (Promega, Madison, WI, USA). Mouse-PAI-1 primers used for RT-PCR were 5 0 -CCACAA AGG TCTCATGGACCAT-3 0 and 5 0 -TGAAAGTGTTGTG CCCTCCAC-3 0 (Maezawa et al., 2006) . RT-PCR was carried out essentially as previously described (Louria-Hayon et al., 2009) .
Tumorigenicity in nude mice
WT and E6AP KO MEFs, grown according to 3T3 protocol, were infected with a retrovirus expressing H-Ras. The cells were injected subcutaneously into each flank of 6-weeks old female athymic nude mice (10 6 cells per injection, two injections per mouse and six mice each group). Tumors growth was monitored every couple of days and was calculated following equation, where L is length and W is the width of the xenograft: V ¼ (L Â W 2 ) Â 0.5. The mice were killed 8 weeks post injection, and the tumors were dissected and weighed.
